# Metabolic Dysfunction-Associated Steatotic Liver Disease Is Characterized by Enhanced Endogenous Cholesterol Synthesis and Impaired Synthesis/Absorption Balance

**Authors:** Irena Frankovic, Aleksandra Zeljkovic, Ivana Djuricic, Ana Ninic, Jelena Vekic, Minja Derikonjic, Sanja Erceg, Ratko Tomasevic, Milica Mamic, Milos Mitrovic, Tamara Gojkovic

PMC · DOI: 10.3390/ijms26157462 · International Journal of Molecular Sciences · 2025-08-01

## TL;DR

This study shows that people with MASLD have increased cholesterol production in the liver, which may contribute to the disease's progression.

## Contribution

The study identifies enhanced endogenous cholesterol synthesis as a novel characteristic of MASLD.

## Key findings

- MASLD patients had higher lathosterol levels, indicating increased cholesterol synthesis.
- Synthesis markers like lathosterol and desmosterol correlated with non-invasive steatosis indicators.
- Cholesterol absorption markers were similar between MASLD patients and healthy individuals.

## Abstract

Cholesterol accumulation plays a significant role in the pathogenesis of metabolic-dysfunction-associated steatotic liver disease (MASLD), yet changes in cholesterol homeostasis in MASLD remain insufficiently investigated. This study aimed to examine alterations in cholesterol synthesis and absorption by measuring plasma levels of endogenous cholesterol precursors (as markers of synthesis) and phytosterols (as indicators of absorption). A total of 124 MASLD patients and 43 healthy individuals were included. Our results showed higher plasma concentrations of lathosterol in the MASLD group (p = 0.006), in parallel with comparable concentrations of desmosterol (p = 0.472) and all analyzed phytosterols in both groups. Correlation analysis showed that both lathosterol and desmosterol were positively associated with non-invasive hepatic steatosis indices: FLI, HSI, and TyG index (p < 0.01, p < 0.01, and p < 0.05, respectively). Multivariate linear regression further confirmed that these synthesis markers remained significant predictors of FLI (p = 0.010), HSI (p = 0.013), and TyG index (p = 0.002), even after adjusting for other relevant variables. These findings indicate that MASLD is associated with a shift in cholesterol homeostasis towards enhanced endogenous cholesterol synthesis.

## Linked entities

- **Diseases:** metabolic-dysfunction-associated steatotic liver disease (MONDO:0013209), MASLD (MONDO:0013209)

## Full-text entities

- **Diseases:** MASLD (MESH:D008107), hepatic steatosis (MESH:D005234), Metabolic Dysfunction (MESH:D008659), Associated (MESH:D018886)
- **Chemicals:** desmosterol (MESH:D003897), phytosterols (MESH:D010840), Cholesterol (MESH:D002784), lathosterol (MESH:C001521)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12347333/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12347333/full.md

---
Source: https://tomesphere.com/paper/PMC12347333